Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages - PubMed (original) (raw)

Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages

C W Olsen et al. J Virol. 1992 Feb.

Abstract

Antibody-dependent enhancement of virus infection is a process whereby virus-antibody complexes initiate infection of cells via Fc receptor-mediated endocytosis. We sought to investigate antibody-dependent enhancement of feline infectious peritonitis virus infection of primary feline peritoneal macrophages in vitro. Enhancement of infection was assessed, after indirect immunofluorescent-antibody labelling of infected cells, by determining the ratio between the number of cells infected in the presence and absence of virus-specific antibody. Infection enhancement was initially demonstrated by using heat-inactivated, virus-specific feline antiserum. Functional compatibility between murine immunoglobulin molecules and feline Fc receptors was demonstrated by using murine anti-sheep erythrocyte serum and an antibody-coated sheep erythrocyte phagocytosis assay. Thirty-seven murine monoclonal antibodies specific for the nucleocapsid, membrane, or spike proteins of feline infectious peritonitis virus or transmissible gastroenteritis virus were assayed for their ability to enhance the infectivity of feline infectious peritonitis virus. Infection enhancement was mediated by a subset of spike protein-specific monoclonal antibodies. A distinct correlation was seen between the ability of a monoclonal antibody to cause virus neutralization in a routine cell culture neutralization assay and its ability to mediate infection enhancement of macrophages. Infection enhancement was shown to be Fc receptor mediated by blockade of antibody-Fc receptor interaction using staphylococcal protein A. Our results are consistent with the hypothesis that antibody-dependent enhancement of feline infectious peritonitis virus infectivity is mediated by antibody directed against specific sites on the spike protein.

PubMed Disclaimer

Similar articles

• A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.
  Hohdatsu T, Nakamura M, Ishizuka Y, Yamada H, Koyama H. Hohdatsu T, et al. Arch Virol. 1991;120(3-4):207-17. doi: 10.1007/BF01310476. Arch Virol. 1991. PMID: 1659798 Free PMC article.
• Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes.
  Hohdatsu T, Yamada H, Ishizuka Y, Koyama H. Hohdatsu T, et al. Microbiol Immunol. 1993;37(6):499-504. doi: 10.1111/j.1348-0421.1993.tb03242.x. Microbiol Immunol. 1993. PMID: 7694052 Free PMC article.
• A review of feline infectious peritonitis virus infection: 1963-2008.
  Pedersen NC. Pedersen NC. J Feline Med Surg. 2009 Apr;11(4):225-58. doi: 10.1016/j.jfms.2008.09.008. Epub 2009 Feb 28. J Feline Med Surg. 2009. PMID: 19254859 Free PMC article. Review. No abstract available.
• A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination.
  Olsen CW. Olsen CW. Vet Microbiol. 1993 Jul;36(1-2):1-37. doi: 10.1016/0378-1135(93)90126-r. Vet Microbiol. 1993. PMID: 8236772 Free PMC article. Review.

Cited by

• Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.
  Takano T, Katoh Y, Doki T, Hohdatsu T. Takano T, et al. Antiviral Res. 2013 Aug;99(2):100-7. doi: 10.1016/j.antiviral.2013.04.016. Epub 2013 May 3. Antiviral Res. 2013. PMID: 23648708 Free PMC article.
• mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents.
  Rauch S, Roth N, Schwendt K, Fotin-Mleczek M, Mueller SO, Petsch B. Rauch S, et al. NPJ Vaccines. 2021 Apr 16;6(1):57. doi: 10.1038/s41541-021-00311-w. NPJ Vaccines. 2021. PMID: 33863911 Free PMC article.
• Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines.
  Serwer P. Serwer P. Vaccines (Basel). 2020 Oct 1;8(4):566. doi: 10.3390/vaccines8040566. Vaccines (Basel). 2020. PMID: 33019507 Free PMC article.
• Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets.
  Darnell ME, Plant EP, Watanabe H, Byrum R, St Claire M, Ward JM, Taylor DR. Darnell ME, et al. J Infect Dis. 2007 Nov 1;196(9):1329-38. doi: 10.1086/522431. Epub 2007 Sep 27. J Infect Dis. 2007. PMID: 17922397 Free PMC article.
• TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages.
  Takano T, Hohdatsu T, Toda A, Tanabe M, Koyama H. Takano T, et al. Virology. 2007 Jul 20;364(1):64-72. doi: 10.1016/j.virol.2007.02.006. Epub 2007 Mar 23. Virology. 2007. PMID: 17382365 Free PMC article.

References

1. 1. Nature. 1981 Jan 15;289(5794):189-91 - PubMed
2. 1. J Med Virol. 1981;8(2):103-17 - PubMed
3. 1. J Virol. 1990 Apr;64(4):1437-40 - PubMed
4. 1. J Virol. 1990 Jan;64(1):339-46 - PubMed
5. 1. J Gen Virol. 1987 Jan;68 ( Pt 1):91-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database